We use technology to enhance data-enabled, human-driven healthcare and improve the lives of people with
  • chronic disease
  • mental illness
  • diabetes
  • hypertension
  • obesity
  • dislipidaemia
  • cognitive decline
  • 1 in 3 of us will die from a chronic disease
  • 1 in 4 of us will experience mental health issues.
Holmusk is a healthcare company on a mission to leverage the power of human relationships, technology and data to prevent, manage and reverse chronic disease and mental health issues. Together, we can learn from the experience of every patient.
The only way to fight this is sustainable behaviour change, at scale.
We are Holmusk →
For Community Chronic Care
For Community Chronic Care

Improve real-world outcomes with the most comprehensive digital therapeutics platform and predictive analytics services for chronic care. Engage patients in their daily lives with continuous health management without the need for in-person visits.

For Community Mental Health
For Community Mental Health

Make strides in mental healthcare and research. Longitudinal data analyses can help you to improve detection, screening and diagnosis. Understand causation, develop new therapies and improve existing treatment.

For Employers, Insurers & Benefits Brokers
For Employers, Insurers & Benefits Brokers

Chronic diseases such as diabetes are driving health spending and lowering productivity. Target your at-risk population with scalable, engaging and effective programmes that measurably improve clinical outcomes and reduce costs.

For healthcare providers & research
For healthcare providers & research

Deliver value-based care with improved outcomes at reduced cost, through the use of analytics-powered dashboards and decision support. Take a leap forward with simulation modelling and insight generation.

For Pharma & CROs
For Pharma & CROs

Reap the benefits of Real World Insight based on the analysis of large data sets characterising disease progression. Identify which patients are best suited to new drugs, quantify long-term cost reductions, and redesign clinical trial criteria.

Our partners include
Let us tell you more.

Email us to start the conversation

Email us →